File HB4470 ("Illinois blocks pay-for-delay drug deals") is before the Illinois Legislature and has not been decided. Latest step (March 27, 2026): Rule 19(a) / Re-referred to Rules Committee.
Illinois file HB4470, before the Illinois Legislature. Still to be decided as of 2026-03-27.
Generic drugs may reach market faster, lowering your prescription costs By presuming that settlement agreements paying generic makers to delay market entry are anticompetitive, the law removes a legal tool brand manufacturers use to keep cheaper alternatives off shelves, potentially allowing generics to launch sooner and reduce what Illinois residents pay for prescriptions.
Health insurers and state Medicaid program could save millions annually Faster generic entry and increased price competition reduce total drug spending across the healthcare system, lowering costs for employer-sponsored plans, individual insurers, and the state's Medicaid program, which can redirect savings to other medical services.
Law only applies to Illinois-based disputes; enforcement depends on AG resources The statute covers only agreements negotiated or involving pharmaceutical sales in Illinois, leaving most multi-state settlements outside its reach, and the Attorney General's office will need sufficient resources to investigate and litigate new cases effectively.
Creates the Prohibition on Anticompetitive Pharmaceutical Practices Act. Provides that, except as specified, a court before which the Attorney General brings an action under the Act shall presume that a resolution agreement that ends a dispute over an alleged infringement of a patent, or a violation of other protection for a protected drug, has anticompetitive effects and is a violation of the Act if, as part of or in connection with the resolution agreement, an alleged infringer: (1) receives an item of value; or (2) agrees to limit or stop researching, developing, manufacturing, marketing, or selling a competing drug. Provides that a resolution agreement does not violate the Act and a party to the resolution agreement may overcome the presumption of anticompetition if the party, by a preponderance of evidence, can demonstrate that: (1) the item of value that the alleged infringer received is fair and reasonable compensation solely for other goods or services that the claimant promised to provide to the alleged infringer; or (2) the agreement has directly generated procompetitive benefits within the relevant market and the procompetitive benefits of the resolution agreement favor
Read the official record for HB4470
See everything up for a vote · This week in Illinois · See what we have filed with the clerk